Spyre Therapeutics, Inc.

The table below shows Spyre Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Spyre Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2025. Over the 10 fiscal years shown, annual revenue declined from $4.63M (FY 2016) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.